Silence Therapeutics (SLN) Other Working Capital Changes (2019 - 2025)
Historic Other Working Capital Changes for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to -$5.3 million.
- Silence Therapeutics' Other Working Capital Changes fell 156013.45% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.9 million, marking a year-over-year decrease of 52845.95%. This contributed to the annual value of $457998.0 for FY2024, which is 10443.67% up from last year.
- Silence Therapeutics' Other Working Capital Changes amounted to -$5.3 million in Q3 2025, which was down 156013.45% from -$3.0 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Other Working Capital Changes ranged from a high of $2.7 million in Q4 2023 and a low of -$24.2 million during Q4 2024
- Moreover, its 5-year median value for Other Working Capital Changes was -$920499.3 (2022), whereas its average is -$2.4 million.
- Per our database at Business Quant, Silence Therapeutics' Other Working Capital Changes surged by 28716.81% in 2023 and then tumbled by 156013.45% in 2025.
- Silence Therapeutics' Other Working Capital Changes (Quarter) stood at -$3.6 million in 2021, then surged by 119.72% to $701411.1 in 2022, then soared by 287.17% to $2.7 million in 2023, then tumbled by 989.66% to -$24.2 million in 2024, then soared by 77.93% to -$5.3 million in 2025.
- Its Other Working Capital Changes stands at -$5.3 million for Q3 2025, versus -$3.0 million for Q2 2025 and $592000.0 for Q1 2025.